Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond S Turner

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 30, 2022
Increasing access to cognitive screening in the elderly: Applying natural language processing methods to speech collected over the telephoneCatherine Diaz-Asper, Chelsea Chandler, Raymond S Turner, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 29, 2023
An explainable machine learning model of cognitive decline derived from speechChelsea Chandler, Catherine Diaz-Asper, Raymond S Turner, et al.
Alzheimer Disease and Associated Disorders|April 11, 2017
The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive ImpairmentNed Sacktor, Anja Soldan, Maura Grega, et al.
Neurotoxicity Research|June 16, 2009
Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversyRicardo Capone, Felipe Garcia Quiroz, Panchika Prangkio, et al.
The Journal of Prevention of Alzheimer'S Disease|January 7, 2026
Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's diseaseJames W Kupiec, Anton P Porsteinsson, Raymond S Turner, et al.
Annals of Clinical and Translational Neurology|August 8, 2023
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairmentMark Monane, Kim G Johnson, B Joy Snider, et al.
Annals of Neurology|May 30, 2020
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's DiseaseRaymond S Turner, Michaeline L Hebron, Abigail Lawler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 1, 2023
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's diseaseJustin Bushnell, Dustin B Hammers, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Ani Eloyan, Maryanne Thangarajah, Na An, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 30, 2022
Increasing access to cognitive screening in the elderly: Applying natural language processing methods to speech collected over the telephoneCatherine Diaz-Asper, Chelsea Chandler, Raymond S Turner, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 29, 2023
An explainable machine learning model of cognitive decline derived from speechChelsea Chandler, Catherine Diaz-Asper, Raymond S Turner, et al.
Alzheimer Disease and Associated Disorders|April 11, 2017
The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive ImpairmentNed Sacktor, Anja Soldan, Maura Grega, et al.
Neurotoxicity Research|June 16, 2009
Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversyRicardo Capone, Felipe Garcia Quiroz, Panchika Prangkio, et al.
The Journal of Prevention of Alzheimer'S Disease|January 7, 2026
Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's diseaseJames W Kupiec, Anton P Porsteinsson, Raymond S Turner, et al.
Annals of Clinical and Translational Neurology|August 8, 2023
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairmentMark Monane, Kim G Johnson, B Joy Snider, et al.
Annals of Neurology|May 30, 2020
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's DiseaseRaymond S Turner, Michaeline L Hebron, Abigail Lawler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 1, 2023
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's diseaseJustin Bushnell, Dustin B Hammers, Paul Aisen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Ani Eloyan, Maryanne Thangarajah, Na An, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Pageof 2